Fieldview Capital Management LLC Acquires Shares of 6,486 HealthEquity, Inc. $HQY

Fieldview Capital Management LLC acquired a new stake in HealthEquity, Inc. (NASDAQ:HQY) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 6,486 shares of the company’s stock, valued at approximately $594,000.

A number of other hedge funds have also recently modified their holdings of HQY. Acumen Wealth Advisors LLC purchased a new position in shares of HealthEquity in the fourth quarter valued at about $27,000. Caitong International Asset Management Co. Ltd increased its position in shares of HealthEquity by 1,723.5% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock valued at $28,000 after acquiring an additional 293 shares during the period. Torren Management LLC purchased a new position in shares of HealthEquity in the fourth quarter valued at about $40,000. Northwestern Mutual Wealth Management Co. increased its position in shares of HealthEquity by 190.4% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 604 shares of the company’s stock valued at $55,000 after acquiring an additional 396 shares during the period. Finally, Larson Financial Group LLC increased its position in shares of HealthEquity by 24.4% in the third quarter. Larson Financial Group LLC now owns 628 shares of the company’s stock valued at $60,000 after acquiring an additional 123 shares during the period. Hedge funds and other institutional investors own 99.55% of the company’s stock.

Insider Buying and Selling

In related news, EVP Delano Ladd sold 7,500 shares of the business’s stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $90.00, for a total transaction of $675,000.00. Following the sale, the executive vice president owned 91,141 shares of the company’s stock, valued at $8,202,690. The trade was a 7.60% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Henry Fiore sold 3,142 shares of the business’s stock in a transaction dated Friday, May 29th. The stock was sold at an average price of $95.00, for a total transaction of $298,490.00. Following the sale, the executive vice president directly owned 59,113 shares in the company, valued at $5,615,735. The trade was a 5.05% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 13,081 shares of company stock valued at $1,193,000 over the last quarter. Corporate insiders own 1.60% of the company’s stock.

HealthEquity Trading Down 1.6%

Shares of HQY opened at $86.97 on Tuesday. The firm’s 50-day moving average price is $84.69 and its 200-day moving average price is $85.62. The firm has a market capitalization of $7.27 billion, a price-to-earnings ratio of 32.57, a PEG ratio of 1.49 and a beta of 0.21. The company has a current ratio of 3.44, a quick ratio of 3.44 and a debt-to-equity ratio of 0.46. HealthEquity, Inc. has a 1-year low of $72.76 and a 1-year high of $106.60.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings data on Thursday, May 28th. The company reported $1.24 EPS for the quarter, topping the consensus estimate of $1.11 by $0.13. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. The business had revenue of $354.64 million for the quarter, compared to analyst estimates of $352.02 million. The company’s revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Sell-side analysts anticipate that HealthEquity, Inc. will post 3.92 EPS for the current year.

Analyst Ratings Changes

A number of brokerages have recently weighed in on HQY. UBS Group set a $110.00 target price on shares of HealthEquity in a research note on Tuesday, February 17th. Royal Bank Of Canada lifted their target price on shares of HealthEquity from $100.00 to $108.00 and gave the company an “outperform” rating in a research note on Wednesday, June 3rd. BTIG Research cut their target price on shares of HealthEquity from $130.00 to $110.00 and set a “buy” rating on the stock in a research note on Tuesday, February 17th. Citigroup reaffirmed a “market outperform” rating on shares of HealthEquity in a research note on Monday, June 1st. Finally, Wall Street Zen raised shares of HealthEquity from a “hold” rating to a “buy” rating in a research note on Saturday, June 6th. One analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $110.57.

HealthEquity Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.